Skip to main content
Clinical Trials/IRCT20120314009297N9
IRCT20120314009297N9
Recruiting
Phase 2

Comparison of the efficacy and safety of mirtazapine and hydroxyzine in the treatment of uremic pruritus in hemodialysis patients: A randomized, double-blind controlled clinical trial

Mazandaran University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
remic pruritus.
Sponsor
Mazandaran University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age older than 18 years
  • Hemodialysis for at least 3 months and having itch despite the adequacy of hemodialysis (Kt/V \> 1\.2\)
  • 5D\-itch score more than 5
  • PSQI score equal and above 5

Exclusion Criteria

  • Anemia ( Hemoglobin less than 7 g/dL)
  • Hyperparathyroidism ( iPTH \> 600 )
  • Phosphorus level higher than 6 mg/dL and calcium higher than 10\.5 mg/dL, or calcium multiplied by phosphorus higher than 60
  • Chronic skin diseases with itching which not related to uremia caused by kidney failure, such as psoriasis, dermatitis, and lichen planus.
  • Chronic liver failure or high bilirubin level (1\.5 times higher than the upper limit of normal) , and ALT, AST more than 5 times higher than the upper limit of normal.
  • Untreated hypothyroidism
  • Patients with psychiatric disorders, such as bipolar disorder, mental retardation, cognitive\-functional disorder, or use of any psychotropic medication during the past month.
  • History of suicide or patients with suicidal ideation
  • Inability to receive oral medication
  • Use of corticosteroids and opium

Outcomes

Primary Outcomes

Not specified

Similar Trials